Related by context. All words. (Click for frequent words.) 71 histological subtype 71 detecting precancerous 69 histologic subtype 69 Squamous cell 69 mutated K ras 69 breast endometrial 69 Papillary 69 Colon polyps 69 nodal metastasis 69 nonmetastatic 69 pancreatic lung 68 colorectal adenocarcinoma 68 fibrosarcoma 68 epithelial tumors 68 Squamous 68 localized prostate 68 invasive lobular 68 bladder ovarian 68 lymphomas leukemias 68 squamous cell lung cancer 68 basal cell skin 68 NMIBC 68 lymphoid tumors 67 thyroid carcinoma 67 Human papillomavirus 67 metastatic gastric 67 malignant lymphoma 67 HNSCC 67 non mutated KRAS 67 LHRH receptor positive 67 neoplasias 67 testicular tumors 67 obstructive coronary artery 67 unresectable tumors 67 hormone receptor negative 67 gastric carcinoma 67 HER2 expression 66 Glioblastoma multiforme GBM 66 renal cell carcinomas 66 Leukemias 66 Leydig cell 66 Chronic lymphocytic leukemia CLL 66 pancreatic adenocarcinoma 66 osteosarcomas 66 squamous cell carcinoma SCC 66 ductal breast cancer 66 precancerous condition 66 precancerous tumors 66 ductal adenocarcinoma 66 urothelial carcinoma 66 metastatic pancreatic 66 recurrent metastatic 66 ovarian endometrial 66 EGFR mutation positive 66 pancreatic endocrine 66 precancerous cervical 66 cisplatin resistant 66 malignant neoplasm 66 allogeneic HSCT 66 bronchoalveolar 66 HER2 amplified 66 metastatic bladder 66 basal cell nevus syndrome 66 oesophageal adenocarcinoma 66 papillary renal cell carcinoma 66 benign noncancerous 65 immunocompetent 65 bladder tumors 65 precursor lesions 65 serous ovarian cancer 65 prostate carcinomas 65 Endometrial 65 Cholangiocarcinoma 65 Chlamydia psittaci 65 BRCA deficient 65 prostate cancer CaP 65 peritoneal cancer 65 GISTs 65 prostate carcinoma 65 Basal cell 65 HER2 positive cancers 65 tumors GIST 65 Immunohistochemical staining 65 PCNSL 65 Chronic lymphocytic leukemia 65 advanced adenoma 65 nonmelanoma 65 enteroviral 65 gastric adenocarcinoma 65 latent celiac disease 65 carcinoma HCC 65 histologically proven 65 hepatocellular carcinoma liver 65 invasive ductal 65 pancreatic ductal 65 urothelial cancer 65 precancers 65 cervical lymph node 65 colorectal adenoma 65 solar keratosis 65 refractory gastrointestinal stromal 65 Hair follicle 65 anal lesions 65 acute myeloid 65 GSTT1 65 colorectal gastric 65 diagnose coronary artery 65 pretreatment serum 65 intraepithelial neoplasia 64 Estrogen receptor positive 64 BCG vaccinated 64 situ LCIS 64 malignant prostate 64 colorectal tumor 64 papillary carcinoma 64 candidemia 64 tumor histology 64 metastatic lymph nodes 64 MALT lymphoma 64 anal intraepithelial neoplasia 64 lymphoproliferative disease 64 Circulating tumor cells 64 resected pancreatic cancer 64 testicular germ cell 64 malignant cancerous 64 leukemias lymphomas 64 metastatic malignant 64 alpha1 antitrypsin deficiency 64 smoldering myeloma 64 vaginal lesions 64 BRAF V#E mutation 64 urinary bladder cancer 64 hematopoietic cancers 64 bronchoalveolar lavage 64 esophageal gastric 64 diagnostic biomarker 64 nonsmall cell lung cancer 64 nonmelanoma skin cancers 64 enteroviral infection 64 cirrhosis liver failure 64 benign nodules 64 T1c 64 GBA mutations 64 hormone receptor status 64 HER2 amplification 64 bile duct cancers 64 squamous carcinoma 64 histopathologic examination 64 metastatic basal cell 64 intestinal polyps 64 lymphoproliferative disorders 64 orchitis 64 liver metastasis 64 Basal Cell 64 malignant ascites 64 transfusion syndrome 64 colorectal carcinoma 64 histological diagnosis 64 BRCA1 BRCA2 64 deCODE ProstateCancer TM 64 peritoneal carcinomatosis 64 Squamous cell carcinomas 64 refractory Hodgkin 64 EGFR blockers 64 GSTP1 63 ANCA associated 63 dysplastic lesions caused 63 metastatic renal 63 precancerous tissues 63 pretransplant 63 alveolar rhabdomyosarcoma 63 cervical intraepithelial neoplasia 63 Adjuvant chemotherapy 63 antiphospholipid antibodies 63 myelodysplastic myeloproliferative diseases 63 gastrointestinal stromal tumors GISTs 63 non resectable metastatic 63 neoplasm 63 endometrial hyperplasia 63 malignant brain 63 Epstein Barr virus EBV 63 bladder carcinoma 63 ductal carcinomas 63 advanced adenomas 63 FluCAM arm 63 neuroendocrine cancers 63 lung pancreatic 63 oligodendrogliomas 63 ovarian breast 63 intracranial tumors 63 metachronous 63 prostate adenocarcinoma 63 acute lymphoblastic 63 multifactorial disease 63 metastatic neuroendocrine tumors 63 malignant ovarian 63 Candida infection 63 CP CPPS 63 SSc 63 ALI ARDS 63 Squamous Cell 63 hypermethylated 63 leiomyomas 63 pre malignant lesions 63 lumbar disk herniation 63 tumor subtype 63 gonococcal infection 63 prostate cancer metastases 63 cells multiply uncontrollably 63 ovarian pancreatic 63 basal cell carcinoma BCC 63 pancreatic neuroendocrine 63 AGTR1 63 deep venous thromboses 63 pancreatic prostate 63 leukemia multiple myeloma 63 Opportunistic infections 63 chronic hepatitis cirrhosis 63 uveal melanoma 63 SETDB1 63 seropositivity 63 radioimmunotherapy RIT 63 bronchoalveolar lavage BAL 63 HIV HCV coinfected 63 dysplastic lesions 63 metaplasia 63 Nonalcoholic fatty liver 63 premalignant lesion 63 adenomatous 63 B7 H3 63 ductal cancer 63 noncancerous prostate 63 sarcoid 63 pediatric acute lymphoblastic 63 epithelial ovarian 63 bronchoalveolar lavage fluid 63 idiopathic PAH 63 hepatorenal syndrome 63 Intravenous immunoglobulin 63 TMPRSS2 ERG fusion 63 thymectomy 63 deCODE BreastCancer 63 pituitary adenomas 63 prostate cancer PCa 63 tumorigenicity 63 skeletal metastases 63 pilocytic astrocytomas 63 colorectal neoplasms 63 proximal colon 63 pituitary adenoma 63 surgically resectable 63 haematopoietic stem cell 63 minimally symptomatic 63 Hurthle cell 63 etiologic agent 63 apocrine 63 cells overexpressing 63 Synovial sarcoma 63 recurrent glioblastoma multiforme 63 underwent surgical resection 63 syngeneic 63 ASCUS 62 cutaneous melanoma 62 CIN2 + 62 astrocytomas 62 adenocarcinomas 62 KRAS mutations occur 62 ovarian carcinoma 62 hyperplastic polyps 62 chronic HBV 62 hypereosinophilic syndrome 62 radiosensitivity 62 commercialize deforolimus 62 BRCA1 mutation carriers 62 seminomas 62 Ribavirin causes 62 kidney urologic 62 #q# deletion 62 Her2 positive 62 Surgical resection 62 mutated p# 62 colorectal polyp 62 Anaplastic 62 metastatic colorectal 62 bladder cancers 62 topically administered 62 operable breast cancer 62 mutant KRAS 62 hepatic fibrosis 62 potent inducer 62 Genetic mutation 62 acid phosphatase PAP 62 KRAS mutation 62 gynecologic malignancy 62 fibroma 62 gonococcal 62 CMV infections 62 post transplant lymphoproliferative 62 K ras mutations 62 NSCLC tumors 62 lichen planus 62 gastric cardia 62 hyperinsulinism 62 neuroblastoma tumors 62 virus HBV 62 prognostic biomarker 62 bronchioloalveolar carcinoma 62 chlamydial 62 bronchogenic carcinoma 62 Uterine cancer 62 Breslow thickness 62 breast pancreatic 62 advanced neoplasia 62 metastatic prostate 62 Kinoid 62 Waldenstrom macroglobulinemia 62 HIV coinfected 62 ovarian cervical 62 castrate resistant 62 cervical carcinoma 62 bullous 62 nonalcoholic steatohepatitis NASH 62 underwent resection 62 TMPRSS2 ERG 62 chronic periodontitis 62 Endometrial cancer 62 colorectum 62 CIN3 62 breast ovary 62 serologically 62 polyps growths 62 myeloperoxidase 62 mucinous 62 spontaneously regress 62 KRAS oncogene 62 Chlamydia trachomatis infection 62 lobular carcinoma 62 Lung transplantation 62 carcinoid tumors 62 relapsed MM 62 lactate dehydrogenase 62 grade squamous intraepithelial 62 treating sarcoma testicular 62 hemorrhagic cystitis 62 Salmonella Typhi 62 cancerdefine 62 obstructive coronary 62 liver scarring 62 FDG uptake 62 intact parathyroid hormone 62 hepatocellular carcinoma HCC 62 sarcomatoid 62 autosomal dominant polycystic kidney 62 laryngeal cancers 62 monogenic 62 chromosomal mutations 62 pulmonary metastasis 62 beta estradiol 62 premalignant lesions 62 Chronic myeloid leukemia 62 fallopian tube carcinoma 62 progesterone receptor negative 62 ADPKD 62 noninfected 62 Amgen Neulasta R 62 transabdominal 62 postoperative delirium 62 ovary uterus 62 ErbB2 positive 62 granulosa cell 62 leiomyoma 62 iPS derived 62 nonseminoma 62 breast carcinomas 62 Glioblastoma Multiforme GBM 62 urethral stricture 62 nasopharyngeal carcinoma 62 stratifying patients 62 Gorlin syndrome 62 prostate bladder 62 locoregional recurrence 62 diabetes mellitus DM 62 mesangial 62 pathologic diagnosis 62 chemically inactivated 62 pulmonary metastases 62 gastrointestinal stromal 62 lung nodule 62 prognostic indicator 62 metastatic adenocarcinoma 62 Carcinoid tumors 62 childhood leukemias 62 distant metastasis 62 Rectal cancer 62 pharyngeal cancer 62 chemoresistant 62 renal carcinoma 62 bacteremic 62 confidence interval #.#-#.# 62 cytomegalovirus retinitis 62 NKX#.# 62 CYT# potent vascular disrupting 62 colorectal lung 61 neuritic 61 heparanase 61 pancreatic ductal adenocarcinoma 61 haematologic 61 recurrent glioblastoma multiforme GBM 61 thymoma 61 benign moles 61 lung metastasis 61 Ph + acute lymphoblastic 61 Enterobacter cloacae 61 pT3 61 Hepatocellular Carcinoma HCC 61 glioblastoma tumor 61 neovascularisation 61 mammary gland tumors 61 chronic prostatitis 61 systemic amyloidosis 61 lung ovary 61 hepatoma 61 pCR 61 HLA DQ2 61 seminoma 61 CC genotype 61 lymphocytic choriomeningitis virus LCMV 61 smoldering multiple myeloma 61 undergone radical prostatectomy 61 Oesophageal cancer 61 HER2 positivity 61 Epstein Barr Virus EBV 61 GBMs 61 pancreas esophagus 61 HER2 overexpression 61 carcinoid tumor 61 Trichomonas vaginalis 61 Polycythemia vera 61 fibroadenomas 61 Mitomycin C 61 colonic polyps 61 Radical prostatectomy 61 castration resistant hormone refractory 61 C. trachomatis 61 Histological 61 HPV subtypes 61 chronic HBV infection 61 lymphatic tissue 61 carotid plaques 61 glutamic acid decarboxylase 61 abnormal Pap smear 61 tonsillar 61 nonhereditary 61 endometrial breast 61 relapsed ALL 61 Glioblastoma multiforme 61 Medullary thyroid cancer 61 Monoclonal antibody 61 papillomaviruses 61 pre cancerous lesion 61 malignant lymphomas 61 Heavy menstrual bleeding 61 Adenomas 61 chorionic villi 61 humanised antibody 61 SOD2 gene 61 coronary artery atherosclerosis 61 gastric cancers 61 J. Clin 61 Neurofibromatosis type 61 KRAS mutated 61 nonproliferative 61 hormonally sensitive 61 Cryptococcus neoformans 61 bone marrow stromal cells 61 immunodeficient 61 PITX2 61 extramedullary 61 cervical lymph nodes 61 p# deficient 61 invasive carcinoma 61 biochemical relapse 61 adjuvant cisplatin 61 ovarian malignancy 61 Dr. Victor Velculescu 61 resistant hormone refractory 61 pathologic examination 61 endometrial ovarian 61 polyp recurrence 61 malignant nodules 61 CMV infection 61 CTVT 61 chlamydial infection 61 hypervascular tumors 61 Prognostic factors 61 vitespen 61 adrenocortical cancer 61 Glioma 61 anal HPV 61 polypoid 61 normal karyotype 61 arterial calcification 61 Leydig cells 61 PLX STROKE targeting 61 amyloid plaque formation 61 lung adenocarcinomas 61 cholangiocarcinoma 61 lung esophageal 61 busulfan 61 ADAMTS# 61 malignant growths 61 urothelial bladder cancer 61 mammographically 61 hamartomas 61 cervical vaginal 61 pT2 61 invasive fungal 61 lymphoid malignancies 61 proton MR spectroscopy 61 Upregulation 61 bone marrow lymph nodes 61 Chlamydia pneumoniae 61 sCJD 61 GnRH analogue 61 paraganglioma 61 Glioblastoma Multiforme 61 BRCA mutation carriers 61 cervical neoplasia 61 caspofungin 61 HLA DR4 61 cervical prostate 61 vesicoureteral reflux VUR 61 biliary tract cancer 61 Benign breast 61 seminal vesicle 61 cervical lesions 61 urine cytology 61 Gleevec resistant 61 SPECT CT imaging 61 demonstrated antitumor activity 61 nonpregnant 61 cervix vagina 61 esophageal squamous cell carcinoma 61 anaplastic astrocytoma AA 61 N. gonorrhoeae 61 percutaneous biopsy 61 oesophageal squamous cell carcinoma 61 lobular cancer 61 refractory metastatic 61 anterior uveitis 61 HepG2 cells 61 grade cervical intraepithelial 61 invasive ductal breast cancer 61 erythema nodosum 61 BRAF mutant 61 polycystic kidneys 61 genitourinary tract 61 RKIP 61 allogeneic bone marrow 61 Genetic variants 61 fluconazole resistant 61 colon rectal 61 microsatellite instability 61 neutropenic sepsis 61 indications Dupuytren 61 fluoroquinolone resistance 61 cystic fibrosis chronic pancreatitis 61 metabolizing enzyme 61 basal cell cancers 61 BRCA2 carriers 61 completely resected 61 anaplastic 61 neoadjuvant setting 61 bacteriuria 61 baseline LDH 61 mesotheliomas 61 chlamydial infections 61 neovascular 61 colorectal tumors 61 eosinophil count 61 neurofibromas 61 HLA DRB1 61 sentinel nodes 61 p# mutation 61 suppresses tumor 61 intraperitoneally 60 congenital deficiency 60 lymphocytic 60 essential thrombocythemia ET 60 subependymal giant cell 60 hepatocellular carcinomas 60 premalignant 60 differentiated thyroid 60 RSV replication 60 acute lymphoid leukemia 60 chronic granulomatous disease 60 cryptococcosis 60 lymphovascular invasion 60 esophagogastric junction 60 cranial irradiation 60 RRM1 60 colon carcinoma 60 SIADH 60 Malignant glioma 60 HbF 60 metabolomic profiles 60 perioperatively 60 Acute myeloid leukemia 60 Demodex 60 gastrointestinal stromal tumor 60 Naive Patients 60 mutated KRAS 60 Phenylketonuria PKU 60 E. faecalis 60 KRAS mutant 60 squamous cell cancers 60 selectively inhibited 60 HER2 neu 60 prospectively enrolled 60 urologic diseases 60 Human papillomavirus HPV 60 inhibin B 60 type 1diabetes 60 metastatic lung cancer 60 medulloblastoma tumors 60 promoter hypermethylation 60 elevated triglyceride levels 60 infused intravenously 60 beta carotene supplementation 60 acute aortic dissection 60 potent suppressor 60 biliary tract 60 Neisseria 60 GIST tumors 60 #.#ng/ml 60 relapsed leukemia 60 discontinued Viread 60 GRNOPC1 contains 60 de novo coronary artery 60 vulvar intraepithelial neoplasia 60 S. aureus isolates 60 vestibular schwannomas 60 Systemic lupus erythematosus 60 #F FDG 60 antiangiogenic agent 60 K ras gene 60 PSA nadir 60 metastatic GIST 60 Chronic myeloid leukemia CML 60 prognostic indicators 60 CD# expression [001] 60 Acute myelogenous leukemia 60 MYCN amplification 60 trophoblast cells 60 squamous histology 60 breast carcinoma 60 tumor xenografts 60 enterococcal 60 haematuria 60 Sudhir Agrawal D.Phil 60 murine model 60 T1DM 60 Folfox 60 underwent prostate biopsy 60 MAGE A3 ASCI 60 HBeAg negative 60 pancreatic carcinoma 60 coinfection 60 sero positive 60 poorer prognosis 60 precancerous cervical lesions 60 pheochromocytoma 60 MSH2 60 recurrent bladder 60 Seewaldt 60 ImmuKnow 60 incidentalomas 60 Bevacizumab Avastin 60 carcinoid 60 HER2 positive breast 60 leukemia AML 60 Aortic stenosis 60 core needle biopsies 60 pancreatic islet 60 Alimentary Tract 60 oncogenic mutations 60 uterine cervix 60 methylation markers 60 ovarian colon 60 node metastases 60 endometrial tumors 60 tryptase 60 perineural invasion 60 chorioamnionitis 60 radioiodine therapy 60 malignant pleural mesothelioma MPM 60 decompensated cirrhosis 60 chronic myeloid 60 extracapsular extension 60 prostatic hyperplasia 60 thyrotropin levels 60 troponin T 60 cytomegalovirus infection 60 intestinal metaplasia 60 bronchial epithelial cells 60 choroidal melanoma 60 metastatic ovarian cancer 60 neoplastic cells 60 nasal carriage 60 tumoral 60 cytoreduction 60 dyskeratosis congenita 60 parotid 60 recurrent venous thromboembolism 60 pre cancerous growths 60 multiple sclerosis psoriasis 60 BRAF mutations 60 grade cervical dysplasia 60 cervical cytology 60 invasive lobular carcinoma 60 autologous transplants 60 Genetic variation 60 biliary tract cancers 60 pancreatic islet cell 60 vivax 60 keratoses 60 intra arterial chemotherapy 60 transgenic rats 60 alpha1 antitrypsin AAT deficiency 60 FLT3 ITD 60 preferentially bind 60 Lymphoid 60 Entamoeba histolytica 60 distal colon 60 atypical hemolytic uremic syndrome 60 impaired glucose metabolism 60 hematological diseases 60 follicular fluid 60 Glioblastomas 60 KRAS mutations 60 Human papilloma virus 60 Lichen planus 60 nonnucleoside reverse transcriptase inhibitors 60 thromboxane A2 60 clinically evaluable 60 Elevated serum 60 asthma rhinitis 60 T. vaginalis 60 Legg Calvé Perthes disease 60 untreated celiac disease 60 bacillus Calmette Guerin 60 Lymphocytic 60 deCODE AF TM 60 LRP5 60 Her2/neu 60 surgically resected 60 gefitinib Iressa 60 testicular cancers 60 ptau 60 methicillin sensitive 60 SNP rs# [001] 60 humoral responses 60 hemodynamically significant 60 immunochemical 60 carcinoembryonic antigen 60 gondii 60 abnormal cytology 60 gastrointestinal stromal tumors GIST 60 infiltrating ductal carcinoma 60 aortic atherosclerosis 60 intracranial atherosclerosis 60 Trichophyton rubrum 60 glycated hemoglobin levels 60 grade serous ovarian 60 HGPIN 60 serologic testing 60 Vidaza azacitidine 60 Basal cell carcinoma 60 rhabdoid 60 A. fumigatus 60 histologically confirmed 60 benign neoplasms 60 cardiotoxic 60 atypical ductal hyperplasia 60 hepatocellular liver 60 acute leukemias 60 thrombocytopenic 60 Mohs micrographic surgery 60 PKCi 60 Roche Herceptin 60 embryonal rhabdomyosarcoma 60 lobular breast cancer 60 Aspergillus fumigatus 60 ovariectomized 60 melanocytic nevi 60 leukaemias 60 telomerase inhibition 60 tumor xenograft models 60 osteopenic 60 autoantibody positive 60 advanced hepatocellular carcinoma 60 KRAS wild 60 hyperplastic 60 TNF blocker therapy 60 immunohistochemical analysis 60 MYH9 gene 60 IgA deficiency 60 polycythemia vera essential thrombocythemia 60 thyrotropin 60 tumor metastases 60 underwent radical prostatectomy 60 idiopathic membranous nephropathy 60 APOL1 60 parathyroid carcinoma 60 myelogenous leukemia 60 pulmonary alveolar 60 serum selenium 60 carotid stenosis 60 oropharyngeal cancer 60 colorectal pancreatic 60 endometriosis ovarian cysts 60 transrectal ultrasound guided 60 GRN# 60 cryosurgery freezing 60 decompensated liver disease 60 abnormal moles 59 cutaneous lupus 59 thyroid nodules 59 bronchopulmonary dysplasia 59 coagulation disorders 59 Hodgkin lymphoma HL 59 pre cancerous actinic 59 CIMZIA TM certolizumab pegol 59 colon adenomas 59 germline mutations 59 precancerous spots 59 Staphylococcus epidermidis 59 gastric corpus 59 Myocarditis 59 uterus womb 59 p# biomarker 59 alanine aminotransferase ALT 59 hMG 59 lung metastases 59 BCG refractory 59 mammary tumors 59 monocytic 59 BRAF V# mutation 59 Cytotoxic T 59 cell carcinomas 59 molecular diagnostic assay 59 primary hyperparathyroidism 59 herpesviruses 59 melanoma lesions 59 miRview ™ squamous 59 molecular abnormalities 59 Small Intestine 59 diagnostic angiography 59 onset diabetes mellitus 59 BRCA2 gene mutation 59 IGFBP 3 59 Lymph node 59 relapsed acute lymphoblastic 59 cryptoxanthin 59 HG PIN 59 cytologic 59 hormonally responsive 59 situ CIS 59 elevated CRP 59 BMPR2 59 Variant Creutzfeldt Jakob Disease 59 localized renal 59 progranulin mutations 59 Univariate analysis 59 Candida species 59 anogenital warts 59 polycystic 59 squamous cell skin 59 Benign tumors 59 postoperative pathology 59 estrogen receptor ER 59 leukemia lymphomas 59 hamartoma 59 familial pancreatic cancer 59 epithelioid 59 synovial cells 59 PCA3 gene 59 MCF7 59 transthyretin amyloidosis 59 Fibroblast 59 proliferative disorders 59 choriocarcinoma 59 5 HT2A serotonin 59 recurrent ovarian 59 Lewy bodies DLB 59 metastatic uveal melanoma 59 enterocolitis 59 microbiologically evaluable 59 clinicopathological features 59 pilocytic astrocytoma 59 GPC5 59 JMML 59 proliferative retinopathy 59 EGFR protein 59 Adenocarcinoma 59 CTAP# 59 EGFR mutant 59 C. pneumoniae 59 eccrine 59 clade B 59 bioluminescence imaging 59 myeloproliferative neoplasms MPNs 59 metastatic lesions 59 pmol L 59 Meningiomas 59 thyroglobulin 59 precancerous polyp 59 hematological relapse 59 de ath 59 spongiform encephalopathies 59 Peptide YY 59 ovarian lung 59 fibroids endometriosis 59 nephrolithiasis 59 Umbilical cord stem cells 59 glioma tumors 59 autoimmune thyroid 59 P aeruginosa 59 ARVD 59 adenomatous polyps 59 neovasculature 59 astrocytoma 59 benign polyps 59 Myelodysplastic Syndrome MDS 59 Ductal carcinoma 59 gastroesophageal 59 polycythemia vera PV 59 HIV1 59 untreated metastatic melanoma 59 basal cell carcinoma squamous 59 Darapladib 59 hypoxia induced 59 scintigraphic 59 complete cytogenetic response 59 bullous pemphigoid 59 anaplastic lymphoma kinase ALK 59 breast uterine 59 uterine tumors 59 MGUS 59 UVB induced 59 Interferon beta 59 enlarged spleens 59 e antigen HBeAg 59 Fatty liver 59 oncogenic HPV 59 varicella infection 59 Diabetic nephropathy 59 methicillin resistance 59 epididymitis 59 Solazed 59 undergoing hematopoietic stem 59 Chronic pancreatitis 59 endometrial biopsy 59 GG genotype 59 NPHP 59 meningeal 59 MLH1 59 renal scarring 59 reduce serum phosphate 59 Acute lymphoblastic leukemia 59 VEGF expression 59 histologic findings 59 resectable 59 cytologic examination 59 chemoembolization 59 aplasia 59 urothelial 59 Helicobacter pylori infection 59 potently inhibit 59 B. fragilis 59 methicillin susceptible Staphylococcus aureus 59 needle aspiration 59 treat enlarged prostate 59 lung epithelium 59 esophagus colon 59 lymphoma subtypes 59 bacterium Neisseria meningitidis 59 distal colon cancer 59 Doxil ® 59 lactate dehydrogenase LDH 59 Aeromonas 59 benign uterine 59 lowest tertile 59 aerodigestive tract 59 catheter angiography 59 paclitaxel cisplatin 59 lymphoid organs 59 photothermal therapy 59 intestinal mucosal